Amber Bio unveils $26M seed round to go broad with ‘multi-kilobase’ RNA editing

The advent of CRISPR technologies for gene editing has opened up the possibility of treating genetic disorders by making precise changes to patients’ DNA or RNA. But two young scientists believe that for the field to have a bigger impact, it needs to go broader.

Basem Al-Shayeb and Jacob Borrajo…
Click here to view original post